The NeuroMab facility is accepting suggestions as to potential targets. Requestors should supply NeuroMab with a scientific justification as to the biological importance of the target molecule, the importance of these reagents to the national neuroscience community, and the availability and suitability of existing polyclonal and/or monoclonal antibodies. Also include a list of reagents (synthetic peptides, fusions proteins, full-length cDNAs for transfection in mammalian cells, samples from knockout mice) that will be made available to the NeuroMab staff to facilitate the development and characterization of these NeuroMabs. Submit this information to NeuroMab here, or via e-mail to neuromab@ucdavis.edu. The NeuroMab advisory board, acting in concert with program officials from NINDS and NIMH, will then prioritize the request in the NeuroMab queue.